Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 8, 2008Journal of Clinical OncologyOpen Access

Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLuca MaurilloUniversity of Rome Tor VergataFBFrancesco BuccisanoUniversity of Rome Tor VergataMPMaria Ilaria Del PrincipeUniversity of Rome Tor Vergata

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maurillo et al. (2008) studied this question.

synapsesocial.com/papers/6a0e8a7fa03ab944350454b4https://doi.org/10.1200/jco.2007.15.9814
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial1998 · 2,643 citations
  2. 2Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 study of the Japan adult leukemia study group1993 · 101 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 39,549 citations